ArticleJournal of cancer research and clinical oncology2023

Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms.

Evelyn Kidess et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.